Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular pattern recognition receptors (PRRs) are a specialized class of proteins located within the cytoplasm or endosomal compartments that serve as the primary sensors for the innate immune system. They are responsible for detecting pathogen-associated molecular patterns (PAMPs) from viruses, bacteria, and fungi, as well as damage-associated molecular patterns (DAMPs) released by stressed or dying host cells (Janeway & Medzhitov, 2002, Annu Rev Immunol). Major families include the NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and endosomal Toll-like receptors (TLRs 3, 7, 8, and 9), along with cytosolic DNA sensors like cGAS (Takeuchi & Akira, 2010, Cell). Upon ligand binding, these receptors initiate signaling pathways that culminate in the activation of transcription factors like NF-κB and IRFs, leading to the production of pro-inflammatory cytokines and type I interferons. Dysregulation of these pathways is heavily implicated in the pathogenesis of autoimmune diseases, chronic inflammation, and cancer (Kawai & Akira, 2011, Nat Immunol). In drug development, intracellular PRRs are targeted using agonists to enhance vaccine efficacy and anti-tumor immunity, or using inhibitors to treat autoinflammatory conditions such as gout and cryopyrin-associated periodic syndromes (Mangan et al., 2018, Nat Rev Drug Discov). These receptors are also being explored for their role in neurodegenerative diseases where chronic neuroinflammation is a driver of pathology.
Agonism of endosomal TLRs, RLRs, or the cGAS-STING pathway to stimulate innate immunity and interferon production; Antagonism or inhibition of NLRs (e.g., NLRP3) to suppress inflammasome activation and pro-inflammatory cytokine release.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular pattern recognition receptor (PRR).